Literature DB >> 2940606

Nitrendipine, nifedipine and verapamil inhibit the in vitro formation of irreversibly sickled cells.

S T Ohnishi, K Y Horiuchi, K Horiuchi, M E Jurman, K K Sadanaga.   

Abstract

Nitrendipine, nifedipine and verapamil inhibit the in vitro formation of irreversibly sickled cells. Using a method of forming both dehydrated cells and irreversibly sickled cells in vitro by repeated cycles of sickling and unsickling, the effects of several drugs in inhibiting the formation of these cells were studied. Drugs known as Ca2+ channel antagonists, such as nitrendipine, nifedipine and verapamil were found to inhibit these reactions. Other types of calcium channel blockers, such as lanthanum and zinc, did not inhibit the formation of these cells. The potency of drugs to inhibit irreversibly sickled cell formation was related to the potency of inhibition of calmodulin-activated phosphodiesterase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2940606     DOI: 10.1159/000138177

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  5 in total

1.  Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.

Authors:  J Stuart; P C Stone; Y Y Bilto; A J Keidan
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

Review 2.  Membrane transport of Na and K and cell dehydration in sickle erythrocytes.

Authors:  C Brugnara
Journal:  Experientia       Date:  1993-02-15

Review 3.  Contemporary best practice in the evaluation and management of stuttering priapism.

Authors:  Georgios Kousournas; Asif Muneer; David Ralph; Evangelos Zacharakis
Journal:  Ther Adv Urol       Date:  2017-07-04

4.  Mode of action and comparative efficacy of pharmacological agents that inhibit calcium-dependent dehydration of sickle cells.

Authors:  J C Ellory; G B Nash; P C Stone; S J Culliford; E Horwitz; J Stuart
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

5.  Effects of membrane acting-drugs on plasmodium species and sickle cell erythrocytes.

Authors:  S T Ohnishi; K K Sadanaga; M Katsuoka; W P Weidanz
Journal:  Mol Cell Biochem       Date:  1989 Nov 23-Dec 19       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.